Literature DB >> 9573360

Cloning of the gene encoding the murine clathrin-associated adaptor medium chain mu 2: gene organization, alternative splicing and chromosomal assignment.

H Ohno1, G Poy, J S Bonifacino.   

Abstract

The mu 2 chain of the clathrin-associated adaptor complex AP-2 is a member of the adaptor medium chain family, a group of proteins involved in the sorting of integral membrane proteins in endocytic/exocytic pathways. Here, we report the cloning of the (MMU)CLAPM1 gene encoding the murine mu 2 chain, the first member of the family for which this information has become available. The mu 2 gene is approximately 8.5 kb long and is organized into 12 exons and 11 introns. Two transcripts are generated by alternative splicing of exon 5, a mini-exon of only six nucleotides. Proteins encoded by both transcripts are capable of interacting with tyrosine-based sorting signals, suggesting that they are functionally equivalent. The mu 2 gene is localized to the proximal region of mouse chromosome 16, which is syntenic to the proximal region of human chromosome 3. The isolation and characterization of the mu 2 gene should be instrumental for future studies of the genetics and physiological role of the adaptor medium chains in mammals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573360     DOI: 10.1016/s0378-1119(97)00649-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis.

Authors:  Akiko Nakano-Kobayashi; Masakazu Yamazaki; Takamitsu Unoki; Tsunaki Hongu; Chie Murata; Ryo Taguchi; Toshiaki Katada; Michael A Frohman; Takeaki Yokozeki; Yasunori Kanaho
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

2.  Adaptins: the final recount.

Authors:  M Boehm; J S Bonifacino
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

3.  Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.

Authors:  D Norman; X M Sun; M Bourbon; B L Knight; R P Naoumova; A K Soutar
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.